Global Cytotoxicity Testing Services Market Growth (Status and Outlook) 2025-2031

The global Cytotoxicity Testing Services market size is predicted to grow from US$ 150 million in 2025 to US$ 218 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.

Cytotoxicity testing services involve the evaluation of the toxicity of substances (such as chemicals, drugs, biomaterials, or medical devices) on cells. These services are crucial in various fields including pharmaceuticals, cosmetics, biomaterials research, and environmental science. The main goal is to determine whether a test substance has the potential to damage or kill cells, which can provide important information about its safety and biocompatibility.

United States market for Cytotoxicity Testing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cytotoxicity Testing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cytotoxicity Testing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cytotoxicity Testing Services players cover UL, SGS, iuvo BioScience, Sartorius, Eurofins Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Cytotoxicity Testing Services Industry Forecast” looks at past sales and reviews total world Cytotoxicity Testing Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Cytotoxicity Testing Services sales for 2025 through 2031. With Cytotoxicity Testing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cytotoxicity Testing Services industry.

This Insight Report provides a comprehensive analysis of the global Cytotoxicity Testing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cytotoxicity Testing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cytotoxicity Testing Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cytotoxicity Testing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cytotoxicity Testing Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Cytotoxicity Testing Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
Elution Testing Method
Agar Overlay Method
Direct Contact Method
MTT Assay Method
Others

Segmentation by Application:
Drug
Medical Instruments
Cosmetics and Personal Care
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
UL
SGS
iuvo BioScience
Sartorius
Eurofins Scientific
TÜV SÜD
Nelson Labs
Pacific BioLabs
Emery Pharma
UFAG Laboratorien AG
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
Medicilon

Please note: The report will take approximately 2 business days to prepare and deliver.